TPN-101
Asset
Inhibits LINE-1 reverse transcriptase.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Not known
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Alzheimer's disease
Phase 2, transposonrx.com, Oct 30, 2026
C9orf72-Related amyotrophic lateral sclerosis
Phase 2, transposonrx.com, Oct 30, 2026
In the full profile
- Owner and partners1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.